| Literature DB >> 33983094 |
Javad Sharifi-Rad1,2, Cristina Quispe3, Shabnum Shaheen4, Mohammed El Haouari5,6, Elena Azzini7, Monica Butnariu8, Ioan Sarac8, Marius Pentea8, Karina Ramírez-Alarcón9, Miquel Martorell9,10, Manoj Kumar11, Anca Oana Docea12, Natália Cruz-Martins13,14,15, Daniela Calina16.
Abstract
Cardiovascular ailments are the number one cause of mortalities throughout the globe with 17.9 million deaths per year. Platelet activation and aggregation play a crucial role in the pathogenesis of arterial diseases, including acute coronary syndrome, acute myocardial infarction, cerebrovascular transient ischemia, unstable angina, among others. Flavonoids-rich plant extracts are gaining interest for treating the heart-related problems due to safe nature of these herbal extracts. Consumption of plant-food-derived bioactives, particularly flavonoids, has shown antithrombotic, and cardiovascular protective effects due to its anti-platelet activity. Preclinical and clinical trials have proven that flavonoid-rich plant extracts are protective against the cardiac ailments through anti-platelet aggregation activity. This review aims to highlight the anti-platelet aggregation potential of flavonoids with a key emphasis on the therapeutic efficacy in humans. The mechanism of flavonoids in preventing and treating cardiovascular diseases is also highlighted based on preclinical and clinical experimental trials. Further studies are the need of time for exploring the exact molecular mechanism of flavonoids as anti-platelet aggregation agents for treating heart-related problems.Entities:
Keywords: Flavonoids; anti-platelet aggregation; mechanisms of action; preclinical studies; signaling pathways
Mesh：
Substances：
Year: 2021 PMID： 33983094 DOI： 10.1080/10408398.2021.1924612
Source DB: PubMed Journal: Crit Rev Food Sci Nutr ISSN： 1040-8398 Impact factor: 11.208